We considered that finding the potential targets of G-Rk1 and G-Rg5 would help to elucidate the underlying mechanism of the anti-tumor effect on liver cancer cells when treated with G-Rk1 or G-Rg5. The gene discussed is TLE5; the disease is liver cancer.